Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratories

Abstract Background Along with rapid diagnostic testing, contact tracing, and public health measures, an effective pandemic response incorporates genomics-based surveillance. Large-scale SARS-CoV-2 genome sequencing is a crucial component of the global response to COVID-19. Characterizing the state...

Full description

Bibliographic Details
Main Authors: C. Nadon, M. Croxen, N. Knox, J. Tanner, A. Zetner, C. Yoshida, G. Van Domselaar
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-022-14210-9
_version_ 1811265199506718720
author C. Nadon
M. Croxen
N. Knox
J. Tanner
A. Zetner
C. Yoshida
G. Van Domselaar
author_facet C. Nadon
M. Croxen
N. Knox
J. Tanner
A. Zetner
C. Yoshida
G. Van Domselaar
author_sort C. Nadon
collection DOAJ
description Abstract Background Along with rapid diagnostic testing, contact tracing, and public health measures, an effective pandemic response incorporates genomics-based surveillance. Large-scale SARS-CoV-2 genome sequencing is a crucial component of the global response to COVID-19. Characterizing the state of genomics readiness among Canada’s public health laboratories was necessary to inform strategic planning and deployment of capacity-building resources in the early stages of the pandemic. Methods We used a qualitative study design and focus group discussions, encompassing both technical and leadership perspectives, to perform an in-depth evaluation of the state of pathogen genomics readiness in Canada. Results We found substantial diversity in the state of readiness for SARS-CoV-2 genomic surveillance across Canada. Despite this variability, we identified common barriers and needs in the areas of specimen access, data flow and sharing, computing infrastructure, and access to highly qualified bioinformatics personnel. Conclusions These findings enable the strategic prioritization and deployment of resources to increase Canada’s ability to perform effective public health genomic surveillance for COVID-19 and prepare for future emerging infectious diseases. They also provide a unique qualitative research model for use in capacity building.
first_indexed 2024-04-12T20:19:19Z
format Article
id doaj.art-7a87d1db5eb449b1b3093ef5f81f77f8
institution Directory Open Access Journal
issn 1471-2458
language English
last_indexed 2024-04-12T20:19:19Z
publishDate 2022-09-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj.art-7a87d1db5eb449b1b3093ef5f81f77f82022-12-22T03:18:02ZengBMCBMC Public Health1471-24582022-09-0122111310.1186/s12889-022-14210-9Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratoriesC. Nadon0M. Croxen1N. Knox2J. Tanner3A. Zetner4C. Yoshida5G. Van Domselaar6Division of Enteric Diseases, National Microbiology Laboratory, Public Health Agency of CanadaAlberta Precision Laboratories, Public Health LaboratoryDepartment of Medical Microbiology and Infectious Diseases, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of ManitobaDivision of Science and Technology Cores and Services, Bioinformatics Section, National Microbiology Laboratory, Public Health Agency of CanadaDivision of Science and Technology Cores and Services, Bioinformatics Section, National Microbiology Laboratory, Public Health Agency of CanadaCanadian Public Health Laboratory Network COVID Genomics Program, National Microbiology Laboratory, Public Health Agency of CanadaDepartment of Medical Microbiology and Infectious Diseases, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of ManitobaAbstract Background Along with rapid diagnostic testing, contact tracing, and public health measures, an effective pandemic response incorporates genomics-based surveillance. Large-scale SARS-CoV-2 genome sequencing is a crucial component of the global response to COVID-19. Characterizing the state of genomics readiness among Canada’s public health laboratories was necessary to inform strategic planning and deployment of capacity-building resources in the early stages of the pandemic. Methods We used a qualitative study design and focus group discussions, encompassing both technical and leadership perspectives, to perform an in-depth evaluation of the state of pathogen genomics readiness in Canada. Results We found substantial diversity in the state of readiness for SARS-CoV-2 genomic surveillance across Canada. Despite this variability, we identified common barriers and needs in the areas of specimen access, data flow and sharing, computing infrastructure, and access to highly qualified bioinformatics personnel. Conclusions These findings enable the strategic prioritization and deployment of resources to increase Canada’s ability to perform effective public health genomic surveillance for COVID-19 and prepare for future emerging infectious diseases. They also provide a unique qualitative research model for use in capacity building.https://doi.org/10.1186/s12889-022-14210-9GenomicsCapacity buildingSurveillanceSARS-CoV-2Public health laboratory
spellingShingle C. Nadon
M. Croxen
N. Knox
J. Tanner
A. Zetner
C. Yoshida
G. Van Domselaar
Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratories
BMC Public Health
Genomics
Capacity building
Surveillance
SARS-CoV-2
Public health laboratory
title Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratories
title_full Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratories
title_fullStr Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratories
title_full_unstemmed Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratories
title_short Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratories
title_sort public health genomics capacity assessment readiness for large scale pathogen genomic surveillance in canada s public health laboratories
topic Genomics
Capacity building
Surveillance
SARS-CoV-2
Public health laboratory
url https://doi.org/10.1186/s12889-022-14210-9
work_keys_str_mv AT cnadon publichealthgenomicscapacityassessmentreadinessforlargescalepathogengenomicsurveillanceincanadaspublichealthlaboratories
AT mcroxen publichealthgenomicscapacityassessmentreadinessforlargescalepathogengenomicsurveillanceincanadaspublichealthlaboratories
AT nknox publichealthgenomicscapacityassessmentreadinessforlargescalepathogengenomicsurveillanceincanadaspublichealthlaboratories
AT jtanner publichealthgenomicscapacityassessmentreadinessforlargescalepathogengenomicsurveillanceincanadaspublichealthlaboratories
AT azetner publichealthgenomicscapacityassessmentreadinessforlargescalepathogengenomicsurveillanceincanadaspublichealthlaboratories
AT cyoshida publichealthgenomicscapacityassessmentreadinessforlargescalepathogengenomicsurveillanceincanadaspublichealthlaboratories
AT gvandomselaar publichealthgenomicscapacityassessmentreadinessforlargescalepathogengenomicsurveillanceincanadaspublichealthlaboratories